Gastritis is the most common disorder of the upper digestive tract. It is a common health problem among young adults.It may be acute or chronic. Gastritis remains a social and public health problem in developed and developing countries. Kala Jeera(Nigella Sativa) releases healthy enzymes that speed the body's digestion processes and aid in the smooth breaking down of sternfat, sugars, and carbohydrates. It is also rich in anti-inflammatory and antioxidant properties that ensure a smooth digestion process.Many over-the-counter drugs, claiming to give relief, are introduced overnight and then hurriedly withdrawn on findings of seriousside effects. Under these circumstances, a tried and tested remedy over centuries can be far more safely relied upon. The currentstudy aimed to determine the potential benefits of Kala Jeera water for Gastritis. Using a quasi-experimental design, fifty patientswere selected randomly(n=50) who fulfilled inclusion and exclusion. A purposive sampling technique was used to select thepatients. The data was collected by using a modified gastrointestinal questionnaire. Pretest scoring was done using a modifiedgastrointestinal questionnaire. After that, the subjects were given Jeera Water and advised to continuously drink on an emptystomach early morning, once a day for 4 weeks. A post-test was conducted after 4 weeks of using a self-administration modifiedgastrointestinal questionnaire. Pretest and post-test scores were compared. There is a significant reduction in symptoms likeabdominal bloating, belching after meals, vomiting after eating, constipation or diarrhea, and coated tongue after 4 weeks. Dataanalysis revealed that Kala Jeera water effectively reduced Gastritis. We conclude that Kala Jeera water is a cost-effective naturalgastritis remedy without any side effects. And it is a simple process.

1. Luis JE, Dávila-Collado R, Jarquín-Durán O, Le TD. Epstein–Barr virus and Helicobacter pylori co-infection in nonmalignant gastroduodenal disorders. Pathogens [journal]. 2020;9(104). http://doi:10.3390/pathogens-9020104. (PMC Free article).
2. Demisew G. Factors associated with gastric disease among students of Hawassa University: the case of College of Agriculture students. Am J Theor Appl Stat. 2018;7(6):207-14. http://doi:10.11648/j.ajtas.20180706.12.
3. Pentti S, Heidi-Ingrid M. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657-67. doi: 10.3109/00365521.2015.1019918. (PMC Free article). PMID 25901896.
4. Toscano EP, Madeira FF, Dutra-Rulli MP, Gonçalves LOM, Proença MA, Borghi VS et al. Epidemiological and clinical-pathological aspects of Helicobacter pylori infection in Brazilian children and adults. Gastroenterol Res Pract. 2018;2018:8454125. doi: 10.1155/2018/8454125, PMID 30254670.
5. Marcis L, Olga S, Jelizaveta P, Yaron N. Epidemiology of Helicobacter pylori infection. Wiley Helicobacter. 2018;23(1):e12514.http://doi:10.1111/hel.12514.
6. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299-305. doi: 10.1002/ptr.1309, PMID 12722128.
7. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed. 2013;3(5):337-52. (PMC Free article). doi: 10.1016/S2221-1691(13)60075-1, PMID 23646296.
8. Longo D, Fauc A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison’s principles of internal medicine. 18th ed. McGraw-Hill; 2012. p. 1261-5.
9. Tepes B, O’Connor A, Gisbert JP, O’Morain C. Treatment of Helicobacter pylori infection 2012. Helicobacter. 2012;17;Suppl 1:36-42. doi: 10.1111/j.1523-5378.2012.00981.x, PMID 22958154.
10. Khaleghi S, Taher MT, Naghibi SS, Naghibi SM. Comparison of sequential and routine four drugs therapeutic regiments in Helicobacter pylori eradication. J Gorgan Univ Med Sci. 2013;15(3).
11. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C, et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis. 2004;10(6):1088-94. doi: 10.3201/eid1006.030744. (PMC Free article). PMID 15207062.
12. Kannappan R, Gupta SC, Kim JH, Reuter S, Aggarwal BB. Neuroprotection by spice-derived nutraceuticals: you are what you eat! Mol Neurobiol. 2011;44(2):142-59. doi: 10.1007/s12035-011-8168-2. (PMC Free article). PMID 21360003.
13. Yimer EM, Tuem KB, Karim A, Ur-Rehman N, Anwar F. Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses. Evid Based Complement Alternat Med. 2019;2019:1528635. doi: 10.1155/2019/1528635. (PMC Free article). PMID 31214267.
14. Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa). Chin J Nat Med. 2016;14(10):732-45. doi: 10.1016/S1875-5364(16)30088-7, PMID 28236403.
15. Kabir Y, Shirakawa H, Komai M. Nutritional composition of the indigenous cultivar of black cumin seeds from Bangladesh. Prog Nutr. 2019;21:428-34. doi: 10.23751/pn.v21i1-S.6556.
16. Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med. 1995;25(4):302-8. doi: 10.1111/j.1445-5994.1995.tb01894.x, PMID 8540870.
17. Varma MG, Wang JY, Berian JR, Patterson TR, McCrea GL, Hart SL. The constipation severity instrument: a validated measure. Dis Colon Rectum. 2008;51(2):162-72. doi: 10.1007/s10350-007-9140-0, PMID 18172725.
18. Miller MJS, MacNaughton WK, Zhang XJ, Thompson JH, Charbonnet RM, Bobrowski P, et al. Treatment of gastric ulcers and diarrhea with the Amazonian herbal medicine sangre de grado. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G192-200. doi: 10.1152/ajpgi.2000.279.1.G192, PMID 10898763.
19. Ranjan KN, Shreechanda P, Priyadarshini P, Sampad SS. Herbal drugs in treatment of peptic ulcer. J BiolInnov6. 2017 |ISSN 2277-8330;3:499-508.
20. Bi WP, Man HB, Man MQ. Efficacy and safety of herbal medicines in treating gastric ulcer: a review. World J Gastroenterol. 2014 Dec 7;20(45):17020-8. doi: 10.3748/wjg.v20.i45.17020. PMID 25493014, PMCID PMC4258570.
21. Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29(9):938-46. doi: 10.1111/j.1365-2036.2009.03960.x, PMID 19220208.
22. Dong WG, Cheng CS, Liu SP, Yu JP. Epidemiology of peptic ulcer disease in Wuhan area of China from 1997 to 2002. World J Gastroenterol. 2004;10(22):3377-9. (PMC Free article). doi: 10.3748/wjg.v10.i22.3377, PMID 15484323.
23. Li Z, Zou D, Ma X, Chen J, Shi X, Gong Y, et al. Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol. 2010;105(12):2570-7. doi: 10.1038/ajg.2010.324, PMID 20736940.
24. Fujino S, Suzuki Y, Tanaka T. Cost–benefit analysis of medicinal treatment for gastric ulcers. Long-term model including healing and recurrence. Health Policy. 1985;5(1):45-72. doi: 10.1016/0168-8510(85)90065-x, PMID 10311270.
25. Mason J, Axon AT, Forman D, Duffett S, Drummond M, Crocombe W et al. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Aliment Pharmacol Ther. 2002;16(3):559-68. doi: 10.1046/j.1365-2036.2002.01204.x, PMID 11876711.
26. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM et al. Comparative study of Nigella sativa and triple therapy in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010 Jul-Sep;16(3):207-14. doi: 10.4103/1319-3767.65201, PMID 20616418, PMCID PMC3003218.
27. Hashem-Dabaghian F, Agah S, Taghavi-Shirazi M, Ghobadi A. Combination of Nigella sativa and Honey in Eradication of Gastric Helicobacter pylori Infection. Iran Red Crescent Med J. 2016 Jun 21;18(11):e23771. doi: 10.5812/ircmj.23771, PMID 28191328, PMCID PMC5292131.
28. Kanter M, Demir H, Karakaya C, Ozbek H. Gastroprotective activity of Nigella sativa L. oil and its constituents, thymoquinone against acute alcohol induced gastric mucosal injury in rats. World J Gastroenterol. 2005;11(42):6662-6. doi: 10.3748/wjg.v11.i42.6662, PMID 16425361.
29. Mardy MA, elHaan el A, Nabila M. Thymoquinone: novel gastroprotective mechanism. Eur J Pharmcol. 2012;697(1-3):126-31.
30. Borrelli F, Izzo AA. The plant kingdom is a source of anti-ulcer remedies. Phytother Res. 2000;14(8):581-91. doi: 10.1002/1099-1573(200012)14:8<581::aid-ptr776>3.0.co;2-s, PMID 11113992.
31. Wallace JL. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: current knowledge and future research. Am J Med. 2001;110(1A):19S-23S. doi: 10.1016/s0002-9343(00)00631-8, PMID 11165991.
32. Kinoshita M, Tsunehisa N, Tamaki H. Effect of a comnbination of ecabet sodium and cimitidine on experimentally induced gastric-lesions and gastric-mucosal resistance to ulcerogenic agents in rats. Biol Pharm Bull. 1995;18:223-6. PMID.
33. Toma W, Hiruma-Lima CA, Guerrero RO, Brito AR. Preliminary studies of Mammea americana L. (Gutti ferae) bark/latex extract point to an effective antiulcer effect on gastric ulcer models in mice. Phytomedicine. 2005;12(5):345-50. doi: 10.1016/j.phymed.2003.06.009, PMID 15957368.
34. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ. Mild irritants prevent gastric necrosis through adaptive cytoprotection mediated by prostaglandins. Am J Physiol. 1983;245(1):G113-21. doi: 10.1152/ajpgi.1983.245.1.G113, PMID 6869543.